| Name | Title | Contact Details |
|---|---|---|
William Rompala |
Chief Technology Officer | Profile |
Brad Derstine |
Director, Enterprise Information Technology Systems | Profile |
Johnson Memorial Hospital (IN) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Johnson Memorial Hospital (IN) is based in Franklin, IN. You can find more information on Johnson Memorial Hospital (IN) at www.johnsonmemorial.org
Parker Health is a Mexican American founded company; a powerful global agent of change, driven by minority-led leadership, diversity, and innovation. Our mission is resolute: to advance healthcare and technology into the next century by simplifying complexities and realizing the potential of digital health innovation. At the core of our approach is the groundbreaking Parker EHR – a revolutionary Electronic Health Records Management System™ that redefines interoperability, accessibility, and compliance. This innovation empowers patients, healthcare providers, systems, governments, researchers, and payors through a seamless cloud-based architecture that harmonizes patient-centric data, diagnostics, outcomes, care protocols, practitioner engagement, and more. Headquartered in Washington, DC, Parker Health signifies a global catalyst for transformation, rewriting the rules of healthcare through innovative solutions that forge a brighter future.
Central Michigan Community Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Central Michigan Community Hospital is based in Mount Pleasant, MI. You can find more information on Central Michigan Community Hospital at www.cmch.org
Corwin Medical Care is a Plainfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Heron Therapeutics` Inc. (formerly A.P. Pharma` Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.